Prescription drug · ANDA
Terbutaline Sulfate NDC 0115-2622
Terbutaline sulfate 5 mg/1 · Tablet · Oral · Amneal Pharmaceuticals of New York LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0115-2622-01 | 0011526220100115262201 | 100 TABLET in 1 BOTTLE (0115-2622-01)Marketed from Jun 26, 2001 | |
| 0115-2622-02 | 0011526220200115262202 | 500 TABLET in 1 BOTTLE (0115-2622-02)Marketed from Jun 26, 2001 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Terbutaline Sulfate
- Generic name (nonproprietary)
- terbutaline sulfate
- Active ingredients
- Terbutaline sulfate — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Amneal Pharmaceuticals of New York LLCNDC labeler code 0115
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075877
- Marketing start
- Listing expires
- Identifiers
- Product ID 0115-2622_63142944-3083-4d47-908f-2984144b6c5dSPL ID 63142944-3083-4d47-908f-2984144b6c5dSPL set ID 382dcebb-6e41-4335-818d-b5822e3fb884RxCUI 857677, 857683UNII 576PU70Y8EUPC 0301152622011, 0301152611015
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400115262201followed by a unit qualifier and the quantityPackage 00115-2622-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Terbutaline sulfate tablets are indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.
Excerpt only. Read the full label for complete information.
About NDC 0115-2622
- What is NDC 0115-2622?
- 0115-2622 is the product NDC for Terbutaline Sulfate, Terbutaline sulfate 5 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals of New York LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Terbutaline Sulfate.
- What is the active ingredient?
- Terbutaline sulfate.
- Who is the labeler?
- Amneal Pharmaceuticals of New York LLC, NDC labeler code 0115. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Terbutaline Sulfate?
- 16 other product NDCs are listed under this name. See all Terbutaline Sulfate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Terbutaline Sulfate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Terbutaline Sulfate | Terbutaline sulfate 1 mg/mL | Injection, SolutionSubcutaneous | Henry Schein, Inc. | 0404-9962 | 00404-9962-01 |
| Terbutaline Sulfate | Terbutaline sulfate 2.5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-132 | 24979-0132-0124979-0132-03 |
| Terbutaline Sulfate | Terbutaline sulfate 5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-133 | 24979-0133-0124979-0133-03 |
| Terbutaline Sulfate | Terbutaline sulfate 2.5 mg/1 | TabletOral | Proficient Rx LP | 71205-938 | 71205-0938-0071205-0938-3071205-0938-55+2 more |
| Terbutaline Sulfate | Terbutaline sulfate 5 mg/1 | TabletOral | Proficient Rx LP | 71205-939 | 71205-0939-0071205-0939-3071205-0939-55+2 more |
| Terbutaline Sulfate | Terbutaline sulfate 2.5 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-721 | 62559-0721-01 |
| Terbutaline Sulfate | Terbutaline sulfate 5 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-722 | 62559-0722-01 |
| Terbutaline Sulfate | Terbutaline sulfate 1 mg/mL | Injection, SolutionSubcutaneous | Fresenius Kabi USA, LLC | 63323-665 | 63323-0665-01 |
| Terbutaline Sulfate | Terbutaline sulfate 1 mg/mL | InjectionSubcutaneous | Hikma Pharmaceuticals USA Inc. | 0143-9375 | 00143-9375-10 |
| Terbutaline Sulfate | Terbutaline sulfate 1 mg/mL | InjectionSubcutaneous | Hikma Pharmaceuticals USA Inc. | 0143-9746 | 00143-9746-10 |
Other NDCs under ANDA 075877
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Terbutaline Sulfate | Terbutaline sulfate 2.5 mg/1 | TabletOral | Amneal Pharmaceuticals of New York LLC | 0115-2611 |